Confirmation of HCV Screening Strategies in Primary Care Confirmation of HCV Screening Strategies in Primary Care
This study aimed to validate a proposed risk-based screening algorithm for hepatitis C to be implemented in a primary care setting.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 27, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
The Mighty Virusoid: Hepatitis D
Hepatitis D is a virusoid-like pathogen that causes serious human disease, including scarring and cancer of the liver. It may be more pervasive than originally thought. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 26, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Arbutus Biopharma shares decline as FDA puts hold on drug study application
The Bucks County company's investigational new drug application is for an experimental therapy to treat hepatitis B infections. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 26, 2023 Category: American Health Authors: John George Source Type: news
Africa: 'Vaccinate Against Deadly Diseases Including Covid-19'
[ADAPT] African Vaccination Week is a crucial reminder of the life-saving power of vaccines. From COVID-19 to polio, diphtheria, tetanus, hepatitis B, influenza, rotavirus, measles, and the human papillomavirus (HPV), vaccines offer protection against deadly diseases. With this week falling on the last week of April, there is no better time to prioritize vaccination. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 25, 2023 Category: African Health Source Type: news
ACIP 2023 Recommended Immunization Schedule for Adults ACIP 2023 Recommended Immunization Schedule for Adults
Review vaccine-specific changes in the 2023 immunization schedule for adults aged 19 years and older, including updates to influenza, hepatitis B, and pneumococcal vaccination.Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 24, 2023 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news
Impact of DAA Treatment on Health Utility in Patients With HCV Impact of DAA Treatment on Health Utility in Patients With HCV
How did treatment with direct-acting antivirals impact the quality of life in a cohort of patients with chronic hepatitis C, and did it vary between those treated in hospital or community clinics?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 20, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Dried Blood Spot Test Validated for HIV, Hep B, and Hep C Dried Blood Spot Test Validated for HIV, Hep B, and Hep C
A test for HIV, hepatitis B, and hepatitis C that uses a single dried blood spot could increase testing for these viruses in high-risk and challenging settings, new data show.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 19, 2023 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
South Sudan reports 5 deaths in hepatitis E outbreak
South Sudan has reported five deaths and 91 suspected cases from an outbreak of hepatitis E in the northwest of the country (Source: ABC News: Health)
Source: ABC News: Health - April 18, 2023 Category: Consumer Health News Tags: Health Source Type: news
Africa: Initiative Aims to Prevent Hep C Infection in Marginalized Groups in Low-Income Countries
[UN News] A $31 million investment announced on Tuesday seeks to prevent hepatitis C infection among people who inject drugs and other high-risk populations in low and middle-income countries. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 18, 2023 Category: African Health Source Type: news
CDC: Solicitation of Nominations for Appointment to the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
The Centers for Disease Control and Prevention (CDC) is seeking nominations for the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHACHSPT). The Committee is charged with advising CDC and HRSA on objectives, strategies, policies, and priorities for HIV, viral hepatitis, and other STD prevention and treatment efforts. Nominations are due by October 1, 2023. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - April 17, 2023 Category: Rural Health Source Type: news
Roche ’s Tecentriq plus Avastin reduced the risk of cancer returning in people with certain types of adjuvant liver cancer in a Phase III study
Discussions with health authorities are ongoing and follow-up will continue for the final RFS data and more mature OS data at the next planned analysis.The IMbrave050 study is part of Roche ’s overall commitment to drive fundamental treatment change and improve outcomes for people living with liver cancer. Tecentriq plus Avastin was the first treatment in over a decade to significantly improve OS over the existing standard of care, based on data from the IMbrave150 study.3 The Tecentriq combination quickly became a standard of care in unresectable HCC and is clearly defined as a preferred front-line treatment in multiple...
Source: Roche Media News - April 16, 2023 Category: Pharmaceuticals Source Type: news
Roche ’s Tecentriq plus Avastin reduced the risk of cancer returning in people with certain types of adjuvant liver cancer in a Phase III study
Discussions with health authorities are ongoing and follow-up will continue for the final RFS data and more mature OS data at the next planned analysis.The IMbrave050 study is part of Roche ’s overall commitment to drive fundamental treatment change and improve outcomes for people living with liver cancer. Tecentriq plus Avastin was the first treatment in over a decade to significantly improve OS over the existing standard of care, based on data from the IMbrave150 study.3 The Tecentriq combination quickly became a standard of care in unresectable HCC and is clearly defined as a preferred front-line treatment in multiple...
Source: Roche Investor Update - April 16, 2023 Category: Pharmaceuticals Source Type: news
SoCal hepatitis A case linked to recalled strawberries sold at Costco, Trader Joe's, officials say
Los Angeles County health officials have identified a case of hepatitis A linked to a recall of frozen strawberries sold at Costco, Trader Joe's and other stores. A nationwide recall was issued last month for the organic strawberries that were traced to supplies provided in 2022 by farms in Baja,…#losangelescounty #costco #baja #mexico #fda #nationwide #kirklandsignature (Source: Reuters: Health)
Source: Reuters: Health - April 15, 2023 Category: Consumer Health News Source Type: news
Gap in Hepatitis C Treatment Initiation in First Nations Patients Gap in Hepatitis C Treatment Initiation in First Nations Patients
First Nations groups collaborated in a population-based study that identified shortcomings in care for patients with hepatitis C in Ontario.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 14, 2023 Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news
HCV Treatment Compliance in Patients Transitioning From Prison HCV Treatment Compliance in Patients Transitioning From Prison
What are the individual, provider and system level factors that influence compliance with HCV treatment in patients transitioning from prison to community?Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 14, 2023 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news
